The aortic stent grafts market is experiencing significant growth, driven by advancements in medical technology and an increasing prevalence of cardiovascular diseases, particularly among the aging population. Aortic stent grafts are primarily used for Endovascular Aneurysm Repair (EVAR) and Thoracic Endovascular Aneurysm Repair (TEVAR), offering a minimally invasive solution for aortic aneurysms and other vascular diseases. The market is witnessing innovations such as lower-profile stent grafts, balloon-expandable devices, and custom-made stent grafts designed to offer better flexibility, improved patient outcomes, and reduced procedural complications. Advancements in biocompatible materials, advanced imaging techniques, and stent graft configurations are enhancing the performance of these devices, enabling more precise treatments. Companies such as Medtronic, W.L. Gore & Associates, Terumo Aortic, and Cook Medical are at the forefront, focusing on improving the design, compatibility, and ease of use of these devices. The rising global burden of cardiovascular diseases, combined with increasing awareness and improved healthcare infrastructure, is expected to drive the growth of the aortic stent graft market during the forecast period. Key regions, including North America, Europe, and Asia-Pacific, are anticipated to lead in terms of market share.
